Gilead, Merck Collaborate to Develop Long-Acting HIV Treatment Gilead, Merck Collaborate to Develop Long-Acting HIV Treatment

Gilead and rival Merck said on Monday they will test a combination of their experimental HIV drugs to develop a long-acting treatment for the infection that affects millions worldwide.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news